LAVA Therapeutics N.V. (LVTX)

AI Score

Unlock

1.31

0.08 (6.50%)

At close: Apr 17, 2025, 3:59 PM

1.31

0.00%

After-hours: Apr 17, 2025, 04:00 PM EDT

LAVA Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q2 2020	Q1 2020	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Jun 30, 2020	Mar 31, 2020	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash & Equivalents	35.02M	26.96M	35.09M	43.19M	44.23M	62.66M	87.61M	100.6M	100.33M	64.33M	75.87M	85.72M	151.01M	116.49M	181.22M	185.79M	19.43M	8.34M	-6.54M	1.79M	1.86M	1.84M
Short-Term Investments	41.56M	51.92M	51.71M	51.39M	51.34M	41.96M	24.8M	24.83M	32.53M	28.39M	34.85M	38.43M	47.99M	48.68M	n/a	n/a	n/a	n/a	13.09M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-6.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	91K	114K	144K	256K	319K	326K	346K	982K	809K	711K	718K	750K	902.43K	814.5K	864.08K	843.84K	944.24K	27K	-6.54M	7.11K	7.38K	7.3K
Receivables	n/a	1.02M	1.15M	907K	1.7M	1.38M	3.99M	2.02M	3.25M	53.02M	834K	889K	734K	1.97M	744.95K	656.99K	1.48M	114K	n/a	53.33K	55.35K	54.75K
Inventory	n/a	n/a	n/a	1.00	1.00	1.00	1.00	1.00	1.00	246K	262K	2.00	2.27	2.87M	3.08M	92K	1.23	2.00	n/a	n/a	n/a	n/a
Other Current Assets	1.65M	1.63M	2.22M	n/a	1.63M	n/a	2.12M	-1	-1	n/a	262K	n/a	n/a	1.66M	2.36M	533.99K	811K	194K	n/a	15.04K	15.61K	15.44K
Total Current Assets	79.3M	81.54M	90.17M	96.67M	98.9M	107.92M	118.52M	130.61M	140.53M	147.6M	112.79M	126.69M	154.76M	172.25M	187.98M	187.19M	22.38M	8.65M	6.54M	1.86M	1.93M	1.91M
Property-Plant & Equipment	1.44M	1.71M	1.97M	2.15M	2.49M	2.78M	3.68M	3.69M	2.08M	1.58M	1.8M	2.07M	2.21M	2.23M	1.64M	1.72M	1.84M	1.11M	n/a	280.07K	290.68K	287.52K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.53M	1.82M	2.11M	2.41M	2.81M	3.1M	4.02M	4.67M	2.89M	2.29M	2.52M	2.82M	3.11M	3.06M	2.52M	2.59M	2.78M	1.14M	-6.54M	287.18K	298.06K	294.82K
Total Assets	80.83M	83.36M	92.28M	99.08M	101.71M	111.02M	122.54M	135.28M	143.43M	149.89M	115.31M	129.51M	157.87M	175.31M	190.5M	189.77M	25.16M	9.79M	n/a	2.15M	2.23M	2.2M
Account Payables	2.72M	2.81M	4.16M	3.44M	4.45M	9.38M	5.07M	3.12M	3.96M	7.8M	2.93M	2.66M	2.55M	1.91M	2.17M	1.72M	934K	1.32M	n/a	102.84K	106.73K	105.57K
Deferred Revenue	n/a	n/a	n/a	n/a	2.00	n/a	n/a	n/a	35M	n/a	n/a	485K	1.73M	3.07M	4.54M	5.03M	5.35M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	4.89M	5.76M	5.38M	5.29M	5.28M	4.94M	4.95M	4.85M	4.64M	n/a	n/a	n/a	n/a	-2.09M	-1.87M	n/a	1.47M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	949K	n/a	n/a	n/a	3.3M	n/a	n/a	4.83M	11.07M	4.36M	9.25M	9.87M	6.75M	5.15M	5.53M	12.27M	1.88M	4.69M	n/a	249.44K	258.89K	256.07K
Total Current Liabilities	18.01M	15.2M	14.11M	13.03M	14.94M	20.75M	22.33M	23.57M	21.95M	17.86M	16.73M	16.34M	5.02M	15.08M	16.27M	22.18M	8.81M	6.01M	n/a	352.28K	365.63K	361.64K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.17M	4.33M	4.51M	4.28M	4.08M	3.88M	3.53M	3.6M	2.21M	n/a	310.16K	321.91K	318.4K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1K	5.03M	5.15M	7.02M	6.87M	1.46M	3.25M	n/a	57.71K	59.9K	59.24K
Total Long-Term Liabilities	35.08M	35.16M	35.3M	35.39M	35.59M	35.67M	36.32M	36.43M	35.43M	39.37M	4.54M	4.76M	18.65M	11.08M	11.04M	11.13M	6.99M	5.46M	n/a	367.87K	381.81K	377.65K
Total Liabilities	53.09M	50.36M	49.41M	48.41M	50.53M	56.42M	58.65M	60.01M	57.38M	57.23M	21.27M	21.1M	23.67M	26.16M	27.31M	33.32M	15.8M	11.47M	n/a	720.15K	747.43K	739.29K
Total Debt	5.28M	6.29M	6.16M	6.13M	6.31M	6.2M	6.95M	6.98M	5.45M	4.63M	4.83M	5.1M	5.52M	5.5M	5.12M	4.68M	5.01M	2.21M	n/a	430.5K	446.81K	441.95K
Common Stock	3.72M	3.72M	3.72M	3.71M	3.71M	3.71M	3.71M	3.71M	3.71M	3.71M	3.66M	3.65M	4.14M	4.16M	4.37M	4.16M	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-174.97M	-168.93M	-156.72M	-148.48M	-148.07M	-141.91M	-134.71M	-122.01M	-108.07M	-93.46M	-94.46M	-89.29M	-89.26M	-79.74M	-73.09M	-63.4M	-44.36M	-19.33M	n/a	-3.33M	-3.46M	-3.42M
Comprehensive Income	-12.65M	-10.6M	-12.29M	997K	1.11M	-1.63M	463K	-854K	-4.03M	-12.02M	-7.44M	1.77M	1.33M	5.52M	2.04M	2.04M	684.8K	574K	5.21M	-24.89K	-25.83K	-25.55K
Shareholders Equity	27.75M	32.99M	42.88M	50.66M	51.18M	54.6M	63.89M	75.28M	86.04M	92.66M	94.04M	108.41M	134.19M	149.14M	163.2M	156.46M	9.36M	-1.69M	5.21M	1.43M	1.48M	1.46M
Total Investments	41.56M	51.92M	51.71M	51.39M	51.34M	41.96M	24.8M	24.83M	32.53M	28.39M	34.85M	38.43M	47.99M	41.97M	n/a	n/a	n/a	n/a	13.09M	n/a	n/a	n/a